BeyondSpring (BYSI) Current Deferred Revenue (2020 - 2024)
BeyondSpring's (BYSI) quarterly Current Deferred Revenue came in at $2.0 million in Q2 2024, up 14.28% year-over-year from $1.8 million in Q3 2023, and up 14.28% quarter-over-quarter from $1.8 million in Q4 2023.
Analysis
BeyondSpring (BYSI) Current Deferred Revenue (2020 - 2024) Analysis & Trends
BeyondSpring has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $2.0 million for Q2 2024.
- In Q2 2024, Current Deferred Revenue rose 14.28% year-over-year to $2.0 million; the TTM figure through Jun 2024 stood at $2.0 million (up 14.28% YoY), while the FY2023 annual figure was $1.8 million, up 29.61% from the prior year.
- Current Deferred Revenue came in at $2.0 million for Q2 2024 at BeyondSpring, up from $1.8 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $2.0 million in Q2 2024 to a low of $1.3 million in Q4 2020.
- Average Current Deferred Revenue over 5 years is $1.5 million, with a median of $1.4 million recorded in 2021.
- Year-over-year, Current Deferred Revenue slipped 1.31% in 2022 and advanced 29.61% in 2023.
- Over 5 years, Current Deferred Revenue stood at $1.3 million in 2020, then increased by 1.41% to $1.4 million in 2021, then retreated by 1.31% to $1.4 million in 2022, then grew by 29.61% to $1.8 million in 2023, then increased by 14.28% to $2.0 million in 2024.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $2.0 million in Q2 2024, $1.8 million in Q4 2023, and $1.8 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2.00 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 1.53 Mn |
| Jun 30, 2021 | 1.35 Mn |
| Mar 31, 2021 | 1.35 Mn |
| Dec 31, 2020 | 1.35 Mn |